Correction to: A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma.

Correction to: A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma. Int J Hematol. 2018 Nov 07;: Authors: Fuchida SI, Sunami K, Matsumoto M, Okumura H, Murayama T, Miyamoto T, Otsuka E, Fujishima N, Izumi T, Tamaki S, Hiramatsu Y, Kuroda Y, Shimazaki C, Akashi K, Harada M, Japan Study Group for Cell Therapy and Transplantation (JSCT) Abstract In the original publication of this article, "Conflict of interest" was published incorrectly. The corrected "Conflict of interest" is given below for your reading. PMID: 30406327 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30406327?dopt=Abstract

Source: International Journal of Hematology - November 7, 2018 Category: Hematology Authors: Fuchida SI, Sunami K, Matsumoto M, Okumura H, Murayama T, Miyamoto T, Otsuka E, Fujishima N, Izumi T, Tamaki S, Hiramatsu Y, Kuroda Y, Shimazaki C, Akashi K, Harada M, Japan Study Group for Cell Therapy and Transplantation (JSCT) Tags: Int J Hematol Source Type: research